Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
Anti-MAP2K1 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
MAP2K1 rabbit polyclonal antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
MEK1 Rabbit polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Modifications | Unmodified |
Phospho-MEK1 (Ser298) Rabbit polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
MEK1/2 Rabbit polyclonal Antibody
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
MEK1/2 Rabbit monoclonal Antibody
| Applications | IF, IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- MAP2K1
Applications
- IHC
Isotypes
- IgG
Filter by
Category
Antibody Hosts
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Families
Pathways
- Acute myeloid leukemia (2)
- B cell receptor signaling pathway (2)
- Bladder cancer (2)
- Chemokine signaling pathway (2)
- Chronic myeloid leukemia (2)
- Colorectal cancer (2)
- Dorso-ventral axis formation (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Fc epsilon RI signaling pathway (2)
- Fc gamma R-mediated phagocytosis (2)
- Focal adhesion (2)
- Gap junction (2)
- Glioma (2)
- GnRH signaling pathway (2)
- Insulin signaling pathway (2)
- Long-term depression (2)
- Long-term potentiation (2)
- MAPK signaling pathway (2)
- Melanogenesis (2)
- Melanoma (2)
- Natural killer cell mediated cytotoxicity (2)
- Neurotrophin signaling pathway (2)
- Non-small cell lung cancer (2)
- Oocyte meiosis (2)
- Pancreatic cancer (2)
- Pathways in cancer (2)
- Prion diseases (2)
- Progesterone-mediated oocyte maturation (2)
- Prostate cancer (2)
- Regulation of actin cytoskeleton (2)
- Renal cell carcinoma (2)
- T cell receptor signaling pathway (2)
- Thyroid cancer (2)
- Toll-like receptor signaling pathway (2)
- VEGF signaling pathway (2)
- Vascular smooth muscle contraction (2)